NCT01367392CompletedPhase 4
Confirmation of Clinical Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System
ActiViews Ltd.1 site in 1 country20 target enrollmentStarted: June 1, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- accuracy
Study Overview
Brief Summary
The purpose of this study is to confirm the safety and effectiveness of the ActiSight™ Needle Guidance System with CT-guided percutaneous (through the skin) liver biopsies and ablations . The device used in this study is designed to assist the physician in guiding the needle towards the suspected area. This device does not change the procedure of liver biopsy or ablation. The only difference is that a small adhesive pad is placed on the skin and a miniature video camera is attached to the end of the needle. This camera does not enter the body.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Male or non-pregnant female subjects, between the ages of 18 and 80 at the time of enrollment.
- •Subjects scheduled for clinically indicated CT guided percutaneous needle placements in the liver who meet the desired target population described above.
- •Written informed consent to participate in the study.
- •Ability to comply with the requirements of the study procedures.
- •Verified home address and phone number to facilitate study follow-up.
Exclusion Criteria
- •Significant coagulopathy that cannot be adequately corrected.
- •Subjects who participated in an active stage of any drug, intervention or treatment trial within 30 days of enrollment.
- •Subjects with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study.
- •Subjects who are uncooperative or cannot follow instructions.
- •Mental state that may preclude completion of the study procedure.
- •Pregnant or nursing female subjects.
Outcomes
Primary Outcomes
accuracy
Time Frame: during the procedure
Frequency of placing the needle at a location suitable for the planned intervention, as determined by the investigator reviewing the CT images.
Secondary Outcomes
- radiation(during the procedure)
- total number of scans(during the procedure)
- time(during the procedure)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Safety & Accuracy Study of the ActiSight Needle Guidance System in Patients Undergoing CT-Guided Percutaneous Chest Aspiration and BiopsyBiopsyNCT00819533ActiViews Ltd.40
Completed
Phase 4
Safety and Effectiveness Study for a Needle Guidance System in Lung BiopsiesLung DiseasesNCT01183182ActiViews Ltd.48
Completed
Not Applicable
Safety & Accuracy of the ActiSight Needle Guidance System in Percutaneous Chest Aspiration and BiopsyBiopsyNCT00814450ActiViews Ltd.20
Not yet recruiting
Not Applicable
Single Arm, Prospective, Open-label, Multi-center Clinical Investigation for the Demax Guide WirePeripheral Vascular DiseasesCoronary Artery DiseaseNCT06735846DemaxGroup100
Completed
Not Applicable
Activ-L™ Artificial Disc Treatment of Degenerative Disc Disease in the Treatment of Degenerative Disc DiseaseDegenerative Disc DiseaseNCT00589797Aesculap Implant Systems376